BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 15494551)

  • 1. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice.
    Ralph RJ; Caine SB
    Psychopharmacology (Berl); 2007 Apr; 191(3):731-9. PubMed ID: 17019570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
    Zhang ZJ; Jiang XL; Zhang SE; Hough CJ; Li H; Chen JG; Zhen XC
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):134-8. PubMed ID: 15911136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats.
    Halberda JP; Middaugh LD; Gard BE; Jackson BP
    Synapse; 1997 May; 26(1):81-92. PubMed ID: 9097408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.
    Thomsen M; Ralph RJ; Caine SB
    Exp Clin Psychopharmacol; 2011 Oct; 19(5):342-60. PubMed ID: 21843011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    Witkin JM; Newman AH; Nowak G; Katz JL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ; Taaid N; Swerdlow NR
    Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
    Desai RI; Terry P; Katz JL
    Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.